Zhou Q - Search Results

1

Safety and feasibility of CRISPR-edited T cells in patients with refractory non-small-cell lung cancer.

Lu Y, Xue J, Deng T, Zhou X, Yu K, Deng L, Huang M, Yi X, Liang M, Wang Y, Shen H, Tong R, Wang W, Li L, Song J, Li J, Su X, Ding Z, Gong Y, Zhu J, Wang Y, Zou B, Zhang Y, Li Y, Zhou L, Liu Y, Yu M, Wang Y, Zhang X, Yin L, Xia X, Zeng Y, Zhou Q, Ying B, Chen C, Wei Y, Li W, Mok T. Lu Y, et al. Among authors: zhou x, zhou q, zhou l. Nat Med. 2020 May;26(5):732-740. doi: 10.1038/s41591-020-0840-5. Epub 2020 Apr 27. Nat Med. 2020. PMID: 32341578 Clinical Trial.

2

Improved therapeutic effectiveness by combining recombinant CXC chemokine ligand 10 with Cisplatin in solid tumors.

Li G, Tian L, Hou JM, Ding ZY, He QM, Feng P, Wen YJ, Xiao F, Yao B, Zhang R, Peng F, Jiang Y, Luo F, Zhao X, Zhang L, Zhou Q, Wei YQ. Li G, et al. Among authors: zhou q. Clin Cancer Res. 2005 Jun 1;11(11):4217-24. doi: 10.1158/1078-0432.CCR-04-2117. Clin Cancer Res. 2005. PMID: 15930360

3

SKLB-677, an FLT3 and Wnt/β-catenin signaling inhibitor, displays potent activity in models of FLT3-driven AML.

Ma S, Yang LL, Niu T, Cheng C, Zhong L, Zheng MW, Xiong Y, Li LL, Xiang R, Chen LJ, Zhou Q, Wei YQ, Yang SY. Ma S, et al. Among authors: zhou q. Sci Rep. 2015 Oct 26;5:15646. doi: 10.1038/srep15646. Sci Rep. 2015. PMID: 26497577 Free PMC article.

4

Assessment of programmed cell death ligand-1 expression with multiple immunohistochemistry antibody clones in non-small cell lung cancer.

Pang C, Yin L, Zhou X, Lei C, Tong R, Huang M, Gong Y, Ding Z, Xue J, Zhu J, Wang Y, Ren L, Zhou L, Wang J, Peng F, Zhou Q, Lu Y. Pang C, et al. Among authors: zhou x, zhou q, zhou l. J Thorac Dis. 2018 Feb;10(2):816-824. doi: 10.21037/jtd.2018.01.124. J Thorac Dis. 2018. PMID: 29607153 Free PMC article.

5

[Knocking-out of HIF1α gene by CRISPR/cas9 inhibits proliferation and invasiveness of prostate cancer DU145 cells].

Xu Y, Xu M, Zhang M, Tan J, Su Z, Chen X, Zhou Q. Xu Y, et al. Among authors: zhou q. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2018 Apr 10;35(2):160-164. doi: 10.3760/cma.j.issn.1003-9406.2018.02.003. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2018. PMID: 29652983 Chinese.

6

Publisher Correction: Safety and feasibility of CRISPR-edited T cells in patients with refractory non-small-cell lung cancer.

Lu Y, Xue J, Deng T, Zhou X, Yu K, Deng L, Huang M, Yi X, Liang M, Wang Y, Shen H, Tong R, Wang W, Li L, Song J, Li J, Su X, Ding Z, Gong Y, Zhu J, Wang Y, Zou B, Zhang Y, Li Y, Zhou L, Liu Y, Yu M, Wang Y, Zhang X, Yin L, Xia X, Zeng Y, Zhou Q, Ying B, Chen C, Wei Y, Li W, Mok T. Lu Y, et al. Among authors: zhou x, zhou q, zhou l. Nat Med. 2020 Jul;26(7):1149. doi: 10.1038/s41591-020-0973-6. Nat Med. 2020. PMID: 32555427

7

Large-scale molecular epidemiological analysis of AAV in a cancer patient population.

Qin W, Xu G, Tai PWL, Wang C, Luo L, Li C, Hu X, Xue J, Lu Y, Zhou Q, Wei Q, Wen T, Hu J, Xiao Y, Yang L, Li W, Flotte TR, Wei Y, Gao G. Qin W, et al. Among authors: zhou q. Oncogene. 2021 Apr;40(17):3060-3071. doi: 10.1038/s41388-021-01725-5. Epub 2021 Mar 29. Oncogene. 2021. PMID: 33782545 Free PMC article.

8

Enhanced antitumor effect of the combination of tumstatin gene therapy and gemcitabine in murine models.

Yao B, He QM, Tian L, Xiao F, Jiang Y, Zhang R, Li G, Zhang L, Hou JM, Wang L, Cheng XC, Wen YJ, Kan B, Li J, Zhao X, Hu B, Zhou Q, Zhang L, Wei YQ. Yao B, et al. Among authors: zhou q. Hum Gene Ther. 2005 Sep;16(9):1075-86. doi: 10.1089/hum.2005.16.1075. Hum Gene Ther. 2005. PMID: 16149906

9

Apolipoprotein 4 may increase viral load and seizure frequency in mesial temporal lobe epilepsy patients with positive human herpes virus 6B.

Huang C, Yan B, Lei D, Si Y, Li H, Chen MW, Li L, Chen F, Zhou Q, Zhou D, Li JM. Huang C, et al. Among authors: zhou d, zhou q. Neurosci Lett. 2015 Apr 23;593:29-34. doi: 10.1016/j.neulet.2014.12.063. Epub 2015 Jan 7. Neurosci Lett. 2015. PMID: 25576704

10

The Prognostic Value of the Proportion and Architectural Patterns of Intraductal Carcinoma of the Prostate in Patients with De Novo Metastatic Prostate Cancer.

Zhao J, Liu J, Sun G, Zhang M, Chen J, Shen P, Liu Z, Liao B, Zhang X, Gong J, Chen N, Zeng H; Collaborators. Zhao J, et al. J Urol. 2019 Apr;201(4):759-768. doi: 10.1016/j.juro.2018.10.016. J Urol. 2019. PMID: 30652989

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

20,673 results

Search Page